Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Interest Expenses (2016 - 2023)

Kiora Pharmaceuticals' Interest Expenses history spans 9 years, with the latest figure at $5984.0 for Q4 2023.

  • For Q4 2023, Interest Expenses changed N/A year-over-year to $5984.0; the TTM value through Sep 2024 reached $5984.0, up 538.63%, while the annual FY2025 figure was $19960.0, 6.93% down from the prior year.
  • Interest Expenses reached $5984.0 in Q4 2023 per KPRX's latest filing, up from $937.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $5984.0 in Q4 2023 to a low of $108.0 in Q1 2019.
  • Average Interest Expenses over 5 years is $2031.4, with a median of $937.0 recorded in 2022.
  • Peak YoY movement for Interest Expenses: crashed 64.47% in 2019, then decreased 1.29% in 2021.
  • A 5-year view of Interest Expenses shows it stood at $109.0 in 2019, then surged by 3740.37% to $4186.0 in 2020, then fell by 1.29% to $4132.0 in 2021, then plummeted by 77.32% to $937.0 in 2022, then surged by 538.63% to $5984.0 in 2023.
  • Per Business Quant, the three most recent readings for KPRX's Interest Expenses are $5984.0 (Q4 2023), $937.0 (Q3 2022), and $4132.0 (Q4 2021).